The gospel of millions of people？ Research： Pig cells may cure human Parkinson’s disease.

China Daily Online, June 13th (Gao Linlin) According to the British "Daily Mail" reported on June 12th, a new study shows that transplanting pig cells into human brain may cure Parkinson’s syndrome.

Although the therapy is still in the early experimental stage, it has achieved results in mice, and the condition of four patients who have received cell transplantation is improving. There are indications that this may be a new treatment for Parkinson’s syndrome.

Ken Taylor, the head of Living Cell Technologies, which studies this therapy, firmly believes that this therapy can bring good news to millions of people. He said that this treatment is like implanting a mini "neurochemical factory" in the human brain to promote the growth and repair of new cells.

Parkinson’s syndrome (PD) is a worsening nervous system disease, which will damage the cells in the area of the patient’s brain that controls limb movements, resulting in a decrease in dopamine content in the brain. According to the report, more than 10 million people worldwide suffer from Parkinson’s syndrome, but there is no effective treatment to prevent the disease from worsening, so the findings of this study bring hope to the medical community and patients.

However, how can pig cells cure Parkinson’s syndrome? It is reported that the transplantation therapy uses cells in the choroid plexus of pigs, which is rich in molecules and important chemicals that can keep brain cells healthy. The researchers put choroid plexus cells into 0.5 mm microcapsules and then implanted them into the human brain.

Researchers believe that the implantation of pig cells into the human brain will help human cells that produce dopamine to stay healthy, thus slowing down the deterioration of the disease.

In the initial human trial, the researchers implanted 40 microcapsules into one side of the brain of four patients. In the next 18 months, the researchers found that their situation had improved. In November this year, researchers will announce the results of the experiment of implanting 120 capsules in patients’ brains.